Coriolis Pharma Research GmbH

Coriolis Pharma is a global contract research organization with significant expertise in Formulation Research and Development, Analytical Services under R&D and GMP and non-GMP Manufacturing with innovative high-value biologics, including cell and gene therapy products and vaccines. This expertise guarantees clients from the biopharmaceutical industry to create drug products with global commercial potential from the very beginning of the development process to market approval and beyond.

More than 725 clients – from start-ups to big pharma – already rely on Coriolis’s scientific expertise for liquid and lyophilized drug products. For each and every project, our highly skilled scientists develop customized study designs that align with our customers’ drug development strategies. Founded in 2008 and headquartered in Martinsried near Munich, Germany, Coriolis currently employs more than 200 employees from over 36 nations around the world.